WordNet

English Journal

Effects of olmesartan and imidapril on the plasma adiponectin, P-selectin, and MDA-LDL levels of diabetic nephropathy patients.

Utsumi K, Yasuda F, Watanabe Y, Higo S, Hirama A, Fujita E, Ueda K, Mii A, Kaneko T, Mishina M, Iino Y, Katayama Y.
Clinica chimica acta; international journal of clinical chemistry.Clin Chim Acta.2012 Jan 18;413(1-2):348-9. Epub 2011 Sep 29.
PMID 21983097

Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome.

Fogari R, Zoppi A, Mugellini A, Maffioli P, Lazzari P, Derosa G.SourceDepartment of Internal Medicine and Therapeutics, Centro Ipertensione e Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy. r.fogari@unipv.it
Hypertension research : official journal of the Japanese Society of Hypertension.Hypertens Res.2011 Dec;34(12):1321-6. doi: 10.1038/hr.2011.137. Epub 2011 Aug 4.
To evaluate the relationship between plasma plasminogen activator inhibitor-1 (PAI-1) and angiotensin II (Ang II) changes during treatment with imidapril and candesartan in hypertensive patients with metabolic syndrome. A total of 84 hypertensive patients with metabolic syndrome were randomized to i
PMID 21814211

A Comparison between Imidapril and Ramipril on Attenuation of Ventricular Remodeling after Myocardial Infarction.

Watanabe R, Ogawa M, Suzuki JI, Hirata Y, Nagai R, Isobe M.Source1Department of Cardiovascular Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8519 2Departments of Advanced Clinical Science and Therapeutics 3Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-8655, Japan.
Journal of cardiovascular pharmacology.J Cardiovasc Pharmacol.2011 Nov 29. [Epub ahead of print]
BACKGROUND: Angiotensin converting enzyme (ACE) inhibitors have been used clinically to prevent myocardial infarction (MI). The ACE inhibitors attenuated ventricular remodeling and improved cardiac function by inhibition of matrix metalloproteinases (MMPs) after MI. Although the effect is thought to
PMID 22130106

Long-Term Effect of Imidapril Hydrochloride Compared With Dilazep Hydrochloride Administration on Blood Pressure and Renal Function in Patients With Chronic Glomerulonephritis

Satonaka Hiroshi,Suzuki Etsu,Hayakawa Hiroshi,Nishimatsu Hiroaki,Nagata Daisuke,Oba Shigeyoshi,Kamijo Atsuko,Takeda Ryo,Takahashi Masao,Yamamoto Yuji,Kimura Kenjiro,Hirata Yasunobu
International Heart Journal 46(4), 701-710, 2005
… The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis. … Imidapril (2.5 or 5 mg/day) or dilazep (300 or 450 mg/day) was administered for 3 years. …
NAID 130000068595

Difference in the Incidence of Cough Induced by Angiotensin Converting Enzyme Inhibitors: a Comparative Study Using Imidapril Hydrochloride and Enalapril Maleate

SARUTA Takao,ARAKAWA Kikuo,IIMURA Osamu,ABE Keishi,MATSUOKA Hiroaki,NAKANO Takeshi,NAKAGAWA Masao,OGIHARA Toshio,KAJIYAMA Goro,HIWADA Kunio,FUJISHIMA Masatoshi,NAKAJIMA Mitsuyoshi
Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 22(3), 197-202, 1999-09-01
NAID 10008736750